Shares of Core Laboratories (NYSE:CLB) have earned a consensus rating of “Hold” from the sixteen brokerages that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $111.70.
Several equities analysts have recently weighed in on CLB shares. Deutsche Bank started coverage on shares of Core Laboratories in a research note on Tuesday, October 10th. They issued a “buy” rating and a $109.00 price target on the stock. Zacks Investment Research raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. Royal Bank of Canada reissued a “buy” rating on shares of Core Laboratories in a research note on Wednesday, October 18th. Piper Jaffray Companies set a $97.00 price target on shares of Core Laboratories and gave the stock a “hold” rating in a research note on Monday, October 23rd. Finally, Scotiabank set a $136.00 price target on shares of Core Laboratories and gave the stock a “hold” rating in a research note on Wednesday, October 25th.
Hedge funds have recently modified their holdings of the business. Cubist Systematic Strategies LLC purchased a new position in Core Laboratories during the second quarter worth about $474,000. Goldman Sachs Group Inc. raised its stake in Core Laboratories by 30.5% during the second quarter. Goldman Sachs Group Inc. now owns 89,829 shares of the oil and gas company’s stock worth $9,096,000 after purchasing an additional 21,006 shares during the period. Marble Harbor Investment Counsel LLC raised its stake in Core Laboratories by 4.9% during the third quarter. Marble Harbor Investment Counsel LLC now owns 10,976 shares of the oil and gas company’s stock worth $1,083,000 after purchasing an additional 510 shares during the period. Janus Henderson Group PLC raised its stake in Core Laboratories by 105.2% during the third quarter. Janus Henderson Group PLC now owns 10,264 shares of the oil and gas company’s stock worth $1,013,000 after purchasing an additional 5,262 shares during the period. Finally, Nomura Holdings Inc. purchased a new position in Core Laboratories during the second quarter worth about $426,000.
Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, January 31st. The oil and gas company reported $0.58 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.58. The firm had revenue of $172.00 million for the quarter, compared to the consensus estimate of $171.92 million. Core Laboratories had a net margin of 12.60% and a return on equity of 58.25%. The company’s revenue for the quarter was up 15.1% on a year-over-year basis. During the same period last year, the firm posted $0.41 earnings per share. research analysts anticipate that Core Laboratories will post 2.63 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, February 16th. Shareholders of record on Friday, January 26th will be paid a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 1.94%. The ex-dividend date is Thursday, January 25th. Core Laboratories’s dividend payout ratio (DPR) is presently 117.02%.
TRADEMARK VIOLATION NOTICE: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/07/core-laboratories-clb-given-average-rating-of-hold-by-analysts.html.
About Core Laboratories
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.